Presented By: Alliance for Health Policy
The Pharmaceutical Supply Chain
Time & Location
The COVID-19 pandemic sparked national concern about vulnerabilities in the drug supply chain. Many drugs procured in the United States are manufactured abroad. The pandemic disrupted the production of key pharmaceutical ingredients around the world, sparking fear about resulting shortages of key medicines. The system also struggled to keep pace with rising demand for drugs to treat patients with COVID-19. During this webinar, panelists explored the impact of the pandemic on different facets of the drug supply chain and discussed policy options to strengthen the system.
This webinar is a project of the Alliance for Health Policy and NIHCM Foundation, in collaboration with The Commonwealth Fund.
More Related Articles
November 18, 2020